Skip to content

Opinions of Healthcare Providers About a European Neuromodulation Register

Opinions of Healthcare Providers About a European Neuromodulation Register: an Online Survey

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06030973
Enrollment
100
Registered
2023-09-11
Start date
2023-08-31
Completion date
2023-09-02
Last updated
2023-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuromodulation, Registry, Survey

Brief summary

The goal of this online survey is to gain further insights in the needs and burden for a European registry for neuromodulation, according to healthcare providers.

Interventions

Professionals are asked to complete questions regarding 1) the degree of current participation in a registry, 2) the need for a European registry, 3) the items that should be collected and 4) access to the European registry.

Sponsors

Vrije Universiteit Brussel
CollaboratorOTHER
Moens Maarten
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Male and female adults who are involved in the management of chronic pain and more specifically in neuromodulation for pain (including but not limited to anesthesiologists, neurosurgeons, nurses).

Exclusion criteria

* Not involved in management of chronic pain through neuromodulation.

Design outcomes

Primary

MeasureTime frameDescription
Healthcare providers their current degree of participation in a registry for neuromodulation.Cross-sectional evaluation during 3th Joint Congress of the INS European Chapters (e-INS 2023) in Hamburg in August-September 2023.Degree of participation in a registry for neuromodulation (question).
Healthcare providers their need for a European registry.Cross-sectional evaluation during 3th Joint Congress of the INS European Chapters (e-INS 2023) in Hamburg in August-September 2023.Underlying reasons on why a European registry is needed, or not needed (question).
Items that should be included in a registry for neuromodulation, according to healthcare providers.Cross-sectional evaluation during 3th Joint Congress of the INS European Chapters (e-INS 2023) in Hamburg in August-September 2023.Items that should be collection within a registry, evaluated with a multiple choice question.
Access regulations to European registry for neuromodulation, according to healthcare providers.Cross-sectional evaluation during 3th Joint Congress of the INS European Chapters (e-INS 2023) in Hamburg in August-September 2023.Access regulations, evaluated with a multiple choice question.

Countries

Germany

Contacts

Primary ContactMaarten Moens
stimulusresearchgroup@gmail.com+3224775514
Backup ContactLisa Goudman
stimulusresearchgroup@gmail.com+3224775514

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026